Overcoming Barriers to Narcolepsy Treatment and Looking to the Future
An expert discusses considerations for tailoring narcolepsy treatment plans for patients with complex comorbidities or lifestyle needs, the role of insurance policies, prior authorizations, and specialty pharmacies in treatment access, emerging strategies to improve care in underserved populations, and the role of hypocretin in narcolepsy.
Video content above is prompted by the following:
- What considerations should clinicians keep in mind when tailoring treatment plans for patients with narcolepsy, particularly those with complex comorbidities or lifestyle needs?
- What role do insurance policies, prior authorizations, and specialty pharmacies play in treatment access, and how can clinicians effectively navigate these systems?
- What are some emerging strategies or innovations that may improve accessibility to narcolepsy care in underserved populations?
Value-Based Decision-Making in Metastatic Breast Cancer
September 16th 2021In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.
Read More
